Literature DB >> 20657449

Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-beta-cyclodextrin.

Jiping Wen1, Benguo Liu, Erdong Yuan, Yuxiang Ma, Yongyi Zhu.   

Abstract

In this study a complex of naringenin with hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was prepared to improve the hydrophilicity of naringenin. The physicochemical properties of the complex were analyzed by ultraviolet-visible spectrometry (UV), infrared spectrometry (IR), X-ray diffractometry (XRD), differential scanning calorimetry (DSC). The result showed that naringenin had been molecularly dispersed in the HP-beta-CD matrix, not forming a new compound and HPLC analysis showed that the solubility of naringenin in water was enhanced from 4.38 microg/mL to 1,272.31 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657449      PMCID: PMC6264575          DOI: 10.3390/molecules15064401

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Flavonoids, rich in fruits, teas, vegetables, and medicinal plants, have received the great attention and been studied extensively, since they have many curative effects such as antibacterial, antioxidant, antiviral, analgesic activities, etc [1,2]. However, the poor water and oil solubility of flavonoids limit their application in food and medicine. In our previous works, we proved that the hydrophobicity of flavonoids could be improved by preparing their lecithin complexes [3,4]. Naringenin is a flavonoid which is considered to have a bioactive effect on human health as an antioxidant, free radical scavenger, anti-inflammatory, carbohydrate metabolism promoter, and immune system modulator [5]. Since naringenin is insoluble in water at room temperature, in this study we tried to prepare the complex of naringenin with HP-β-CD to improve its water solubility, which could become the basis of the application of flavonoids in food and medicine.

2. Results and Discussion

2.1. The complex of naringenin and HP-β-CD

In previous studies [6,7], Tommasini improved the solubility and dissolution rate of naringenin by complexation with β-cyclodextrin and the physicochemical properties of the complex were also investigated by NMR, FT-IR, DSC, X-ray. But due to the low solubility of β-cyclodextrin in water (18.5 g/L, 20 °C), the improved solubility of naringenin was still less than 300 μg/mL at 37 °C. Hydroxylpropyl-β-cyclodextrin (HP-β-CD), a hydroxyalkyl derivative of β-cyclodextrin, is an alternative to α-, β- and γ-cyclodextrin (CD), with improved water solubility (>500 g/L, 20 °C). As the first CD derivatives approved by the FDA, HP-β-CDs have been widely applied in the food, agriculture and the pharmaceutical fields [8,9]. In this study, we tried to prepare complexes of naringenin with HP-β-CD to improve the water solubility of naringenin. The complexes were prepared with different molar ratios of HP-β-CD and naringenin, such as 1, 2, 3, and 4. When the molar ratio was set at 1, all of naringenin could be embedded in HP-β-CD. For the purpose of getting the best quality and use the smallest amount of HP-β-CD, we therefore decided to prepare the complex with a molar ratio of 1. The obtained complex was used for the subsequent analysis. The solubility of the complex in water is shown in Figure 1. By forming the complex, the solubility of naringenin in water increased from 4.38 μg/mL to 1,272.31 μg/mL and the water solubility of naringenin was thus significantly improved.
Figure 1

Solubility comparison of naringenin (1) and its complex 2 in water.

Solubility comparison of naringenin (1) and its complex 2 in water.

2.2. UV and IR analysis

The UV spectra of HP-β-CD, naringenin, their physical mixture and the complex are shown in Figure 2. There was no difference between the physical mixture and the complex in the UV analysis. The characteristic absorption peaks of naringenin, the physical mixture and the complex were still present at 287 nm. As shown in Figure 3, the IR spectrum of the physical mixture showed an additive effect of HP-β-CD and naringenin. However, in the spectrum of their complex, some small characteristic absorption peaks of naringenin between 500 and 2,000 cm-1 were almost masked by those of HP-β-CD, and there was no significant difference between the IR spectra of HP-β-CD and the complex. From UV and IR spectra, it was concluded that that some weak physical interactions between naringenin and HP-β-CD could take place during the formation of the complex.
Figure 2

UV spectra of HP-β-CD (1), complex of naringenin and HP-β-CD (2), physical mixture of naringenin and HP-β-CD (3) and naringenin (4).

Figure 3

IR spectra of HP-β-CD (1), naringenin (2),physical mixture of naringenin and HP-β-CD (3) and complex of naringenin and HP-β-CD (4).

UV spectra of HP-β-CD (1), complex of naringenin and HP-β-CD (2), physical mixture of naringenin and HP-β-CD (3) and naringenin (4). IR spectra of HP-β-CD (1), naringenin (2),physical mixture of naringenin and HP-β-CD (3) and complex of naringenin and HP-β-CD (4).

2.3. XRD analysis

The powder X-ray diffraction patterns of HP-β-CD, naringenin, their physical mixture and the complex are shown in Figure 4. The powder diffraction pattern of naringenin displayed sharp crystalline peaks, which is the characteristic of an organic molecule with crystallinity. In contrast, HP-β-CD showed an amorphous structure lacking crystalline peaks. Compared with that of the physical mixture, the crystalline peaks had disappeared in the complex. This suggested that naringenin was molecularly dispersed in the HP-β-CD matrix, although some crystalline signals of naringenin were still detectable in the physical mixture of naringenin and HP-β-CD.
Figure 4

X-ray diffraction patterns of HP-β-CD (1), naringenin (2),complex of naringenin and HP-β-CD (3) and physical mixture of naringenin and HP-β-CD (4).

X-ray diffraction patterns of HP-β-CD (1), naringenin (2),complex of naringenin and HP-β-CD (3) and physical mixture of naringenin and HP-β-CD (4).

2.4. DSC analysis

Figure 5 shows the DSC curves of HP-β-CD, naringenin, their physical mixture and the complex. The DSC curve of naringenin showed an endothermal peak with an onset temperature at about 251.1 °C, which was attributed to the melting of naringenin. The DSC curve of the physical mixture mainly showed the effects of naringenin and HP-β-CD, but the DSC curve of the complex mainly showed the effect of HP-β-CD, in which the characteristic endothermal peaks of naringenin disappeared. It was considered that naringenin had been completely dispersed in HP-β-CD and they should have some interaction, such as the combination of hydrogen bonds or van der Waals force.
Figure 5

DSC curves of naringenin (1), physical mixture of naringenin and HP-β-CD (2), HP-β-CD (3) and complex of naringenin and HP-β-CD (4).

DSC curves of naringenin (1), physical mixture of naringenin and HP-β-CD (2), HP-β-CD (3) and complex of naringenin and HP-β-CD (4).

3. Experimental

3.1. Materials and chemicals

Naringenin (Purity 98%) was purchased from Shaanxi Huike Botanical Development Co., Ltd. HP-β-CD (>99%, DS = 5.5) purchased from Wako Pure Chemical Industries, Ltd. (Chuoku, Osaka, Japan). Other chemicals used were of analytical grade.

3.2. Preparation of the complex of naringenin with HP-β-CD

Naringenin (0.136 g, 0.5 mM) and HP-β-CD (2.8 g, 0.5 mM) were dissolved in ethanol (20 mL) and stirred for 24 h. After the ethanol was removed, the residue was dissolved in water (50 mL) and filtered. The filtrate was frozen at −40 °C for 24 h and then lyophilized (Alpha 1-4, Christ, Germany) and collected. The resultant white power was collected as the complex of naringenin with HP-β-CD.

3.3. Preparation of physical mixture of naringenin and HP-β-CD

Naringenin (0.136 g) and HP-β-CD (2.8 g) were mixed and stirred in a small beaker at room temperature. The obtained product was collected as the physical mixture of naringenin and HP-β-CD.

3.4. Solubility in water

Solubility determination of naringenin was carried out by adding excess naringenin and its complex to water (2 mL) at 25 °C. The liquids were agitated for 24 h, and then centrifuged (15 min, 4,000 rpm). The supernatant (500 μL) was diluted to 10 mL with methanol. After ultrasonic treatment, the content of naringenin was determined by HPLC analysis performed on a Waters Alliance HPLC system (USA), which consisted of a Waters 2695 separations module and a Waters 2487 dual λ absorbance detector. The injection volume was 10 μL and the wavelength for detection was set at 288 nm. The samples were separated on a SunFireTM C18 reversed phase column (4.6 × 250 mm; 5 μm particle size) made by Waters (USA). The mobile phase consisted of methanol and water (7:3) with a flow rate of 1.0 mL/min. Before HPLC analysis, all samples must be passed through a 0.45 μm Millipore filter. The quantitative analysis of naringenin in the samples was based on an external standard. The chromatographic data were recorded and processed by Empower 2 software.

3.5. UV and IR analysis

UV analysis was performed on a TU-1810PC UV spectrophotometer (Purkinje, China) and IR analysis was performed on a TENSOR 27 infrared Spectrophotometer (Bruker, Germany) by the KBr method.

3.6. X-ray diffractometry (XRD)

Monochromatic Cu Ka radiation (wavelength = 1.54056 Å) was produced by a D/MAX 2500V/PC X-ray diffractometer (Rigaku Americas Corporation, Japan). The powders of samples were packed tightly in a rectangular aluminum cell. The samples were exposed to the X-ray beam. The scanning regions of the diffraction angle, 2θ, were 5–60˚. Duplicate measurements were made at ambient temperature. Radiation was detected with a proportional detector.

3.7. Differential scanning calorimetry (DSC)

The samples sealed in the aluminum crimp cell were heated at the speed of 10 °C/min from 0 to 300 °C in the atmosphere of nitrogen (Q200, TA, USA). The data were recorded and processed by Universal Analysis 2000 software (TA, USA).

4. Conclusions

By forming the complex with HP-β-CD, the solubility of naringenin in water was significantly improved. According to UV, IR, XRD, DSC analysis, naringenin in the complex was molecularly dispersed in the HP-β-CD matrix, and not forming a new compound. The obtained complex could be used in food and medicine.
  7 in total

1.  Bioavailability of the flavanone naringenin and its glycosides in rats.

Authors:  C Felgines; O Texier; C Morand; C Manach; A Scalbert; F Régerat; C Rémésy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-12       Impact factor: 4.052

2.  Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin.

Authors:  Silvana Tommasini; Daniela Raneri; Rita Ficarra; Maria Luisa Calabrò; Rosanna Stancanelli; Paola Ficarra
Journal:  J Pharm Biomed Anal       Date:  2004-04-16       Impact factor: 3.935

3.  Preparation and stability of the inclusion complex of astaxanthin with hydroxypropyl-β-cyclodextrin.

Authors:  Chao Yuan; Zhengyu Jin; Xueming Xu; Haining Zhuang; Wangyang Shen
Journal:  Food Chem       Date:  2007-07-27       Impact factor: 7.514

4.  Antioxidant and antiradical activities of flavonoids.

Authors:  S Burda; W Oleszek
Journal:  J Agric Food Chem       Date:  2001-06       Impact factor: 5.279

5.  Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.

Authors:  R Ficarra; S Tommasini; D Raneri; M L Calabrò; M R Di Bella; C Rustichelli; M C Gamberini; P Ficarra
Journal:  J Pharm Biomed Anal       Date:  2002-08-01       Impact factor: 3.935

6.  Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro.

Authors:  Yanping Zou; Yanhua Lu; Dongzhi Wei
Journal:  J Agric Food Chem       Date:  2004-08-11       Impact factor: 5.279

7.  Structure-activity relationship of flavonoids active against lard oil oxidation based on quantum chemical analysis.

Authors:  Ji-Guo Yang; Ben-Guo Liu; Gui-Zhao Liang; Zheng-Xiang Ning
Journal:  Molecules       Date:  2008-12-23       Impact factor: 4.411

  7 in total
  13 in total

Review 1.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

2.  Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.

Authors:  Nechikkad Sulfikkarali; Narendran Krishnakumar; Shanmugam Manoharan; Ramadas Madhavan Nirmal
Journal:  Pathol Oncol Res       Date:  2012-12-12       Impact factor: 3.201

3.  Improved antioxidant, antimicrobial and anticancer activity of naringenin on conjugation with pectin.

Authors:  Jyoti Mundlia; Munish Ahuja; Pradeep Kumar; Viness Pillay
Journal:  3 Biotech       Date:  2019-07-30       Impact factor: 2.406

4.  Preparation, characterization, and antibacterial activity of plaunotol and plaunoi extracts complexed with hydroxypropyl-β-cyclodextrin.

Authors:  Wai Mi Aung; Sarunyoo Songkro; Supreedee Songkharak; Nattha Kaewnopparat; Juraithip Wungsintaweekul
Journal:  Saudi Pharm J       Date:  2022-04-07       Impact factor: 4.562

Review 5.  Flavonoids as dietary regulators of nuclear receptor activity.

Authors:  Yishai Avior; David Bomze; Ory Ramon; Yaakov Nahmias
Journal:  Food Funct       Date:  2013-04-19       Impact factor: 5.396

6.  Development and In Vitro Evaluation of an Innovative "Dietary Flavonoid Supplement" on Osteoarthritis Process.

Authors:  Maria Rosaria Lauro; Lucia Crascí; Francesca Sansone; Venera Cardile; Anna Maria Panico; Giovanni Puglisi
Journal:  Oxid Med Cell Longev       Date:  2017-03-07       Impact factor: 6.543

7.  Neuroprotective and Antioxidant Effect of Naringenin-Loaded Nanoparticles for Nose-to-Brain Delivery.

Authors:  Shadab Md; Nabil A Alhakamy; Hibah M Aldawsari; Hani Zakaria Asfour
Journal:  Brain Sci       Date:  2019-10-15

8.  Comprehensive Characterization of Linalool-HP-β-Cyclodextrin Inclusion Complexes.

Authors:  María Isabel Rodríguez-López; María Teresa Mercader-Ros; Carmen Lucas-Abellán; José Antonio Pellicer; Alfonso Pérez-Garrido; Horacio Pérez-Sánchez; María Josefa Yáñez-Gascón; José Antonio Gabaldón; Estrella Núñez-Delicado
Journal:  Molecules       Date:  2020-11-01       Impact factor: 4.411

9.  Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles.

Authors:  Marta G Fuster; Guzmán Carissimi; Mercedes G Montalbán; Gloria Víllora
Journal:  Nanomaterials (Basel)       Date:  2020-04-10       Impact factor: 5.076

10.  Bioactivity In Vitro of Quercetin Glycoside Obtained in Beauveria bassiana Culture and Its Interaction with Liposome Membranes.

Authors:  Paulina Strugała; Tomasz Tronina; Ewa Huszcza; Janina Gabrielska
Journal:  Molecules       Date:  2017-09-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.